Chapters cover advancements made in recent years in the management of the underlying ischemic retinal conditions that lead to NVG, including the use of anti-vascular endothelial growth factor (anti-VEGF) medications. Additionally, chapters discuss glaucoma surgeries, which have become less invasive in recent years with the advent of microinvasive glaucoma surgery (MIGS). This book offers an up-to-date reference regarding current concepts in the diagnosis, as well as medical, laser, and surgical treatment of NVG in the anti-VEGF era, with attention to the close collaboration between glaucoma specialists and retina specialists. weiterlesen